TCM
BIIB icon

Telos Capital Management’s Biogen BIIB Stock Holding History

Telos Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-720
Closed -$221K – 141
2015
Q4 		$221K Buy
+720
New +$207K 0.12% 137

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Telos Capital Management's BIIB Position: Q1 2016 in Review

Telos Capital Management sold out of Biogen (BIIB) in Q1 2016, closing a stake of 720 shares — an estimated $221K sold.

Telos Capital Management first reported a position in BIIB in Q4 2015 and held it in 1 quarter. The position peaked at $221K in Q4 2015. 947 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

  • Telos Capital Management reported no remaining Biogen position as of Q1 2016 after selling out during the quarter.
  • Telos Capital Management sold 720 Biogen shares in Q1 2016, an estimated $221K.
  • Telos Capital Management first reported a position in Biogen in Q4 2015 and held it in 1 quarter.
  • Telos Capital Management's Biogen position peaked at $221K in Q4 2015.
  • 947 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Telos Capital Management's 13F filing for Q1 2016, filed 28 Apr 2016.